Stay Tuned!

Subscribe to our newsletter to get our newest articles instantly!

Tech News

Visus Therapeutics Announces Positive Topline Clinical Data from Phase 3 Pivotal BRIO-I Trial of BRIMOCHOL PF™ for the Treatment of Presbyopia

BRIMOCHOL PF, a preservative-free eyedrop, successfully met the pre-specified visual acuity primary endpoints for both the US and EU/UK against its active comparators carbachol and brimonidine.

BRIMOCHOL PF successfully demonstrated “contribution-of-elements,” paving the way for the first, and potentially only, fixed-dose combination topical ophthalmic eyedrop for Presbyopia.

BRIMOCHOL PF achieved highly statistically significant near vision improvements over 8 hours and was…

Source link


Techy Nerd

About Author

Leave a comment

Your email address will not be published. Required fields are marked *

You may also like

Tech News

3 ways businesses can strike the ideal marketing and IT balance

We’re seeing two schools of thought emerge on how best to leverage data in the digital media landscape. The first
Software Tech News

Build Smart Biolinks with AI: Introducing the AI Biolink Creator

AI powered content for Bio Links and Marketing.